Physician profile

Shikha Sharma

Cardiovascular Disease · Lapeer, MI

NPI 1508000274

$6,461.27

in general payments reported to CMS, 2019-2025

31 companies · $676 in 2025

The $676 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).

See the full distribution for Cardiovascular Disease

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$1,741.24
Travel and Lodging$903.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Biotronik INC. $2,209.46 2022-2023 Biomonitor
Boston Scientific Corporation $1,561.37 2020-2024 Watchman Access System, Sq-Rx Pulse Generator, Varithena Administration Pack
Novartis Pharmaceuticals Corporation $445.64 2021-2025
Amgen INC. $304.59 2022-2025 Repatha, Repatha
E.R. Squibb & Sons, L.L.C. $245.96 2022-2025 Eliquis, Camzyos
Merck Sharp & Dohme LLC $211.16 2024-2025 Verquvo
Inari Medical, INC. $200.87 2022-2023 Flowtriever Catheter, S, Ct Thrombectomy System Kit
Astrazeneca Pharmaceuticals LP $181.67 2020-2021
Abbott Laboratories $153.24 2019-2025 Cardiomems, Freestyle Libre 3
Pfizer INC. $132.22 2022-2023
Philips North America LLC $123.51 2022-2023
Kiniksa Pharmaceuticals International, Plc $74.38 2024 Arcalyst
Boehringer Ingelheim Pharmaceuticals, INC. $69.95 2024-2025 Jardiance
Janssen Pharmaceuticals, INC $59.50 2022-2024 Xarelto
Bayer Healthcare Pharmaceuticals INC. $42.99 2022
Show all 31 companies
CompanyGeneral paymentsYearsTop products
Pacira Pharmaceuticals Incorporated $41.59 2023 Iovera
Sanofi-Aventis U.S. LLC $41.22 2022
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $40.98 2021-2025 Lifevest
Edwards Lifesciences Corporation $39.82 2022
Convatec INC. $37.51 2023
Alnylam Pharmaceuticals INC. $34.83 2025 Onpattro
Actelion Pharmaceuticals US, INC. $32.45 2025 Uptravi, Opsumit
Corcept Therapeutics $27.40 2025 Korlym
Cardiva Medical, INC. $24.67 2024 Savvywire
Medtronic, INC. $21.38 2022
Amarin Pharma, INC. $19.82 2022
Kestra Medical Technology Services, INC. $18.97 2025 Assure Wcd
Abiomed $18.87 2025
Terumo Medical Corporation $15.81 2024 Metacross Otw, Glidewire
Bardy Diagnostics, INC. $15.35 2022
Medtronic Vascular, INC. $14.09 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Shikha Sharma

$6,461.27

in general payments reported 2019-2025

Years
2019-2025
Top company
Biotronik INC.
Context
The $676 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/159236/shikha-sharma

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.